Investing.com - PTC (NASDAQ: PTC) reported third quarter EPS of $3.47, $1.20 better than the analyst estimate of $2.27. Revenue ...

More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved PTC's ...

PTC Therapeutic's Upstaza gene therapy for patients with genetic disorder AADC deficiency has been recommended for approval in the EU, setting up another test of the commercial prospects for gene ...

Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity ...

PTC Industries Limited is an India-based company, which is engaged in manufacturing of precision metal components for critical applications. It is primarily engaged in the manufacturing of metal ...

Oct 24, 2025, 10:09 PM IST PTC Industries - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order Oct 23, 2025, 5:37 AM IST PTC Industries - Announcement under Regulation 30 ...

Oct 24, 2025, 8:42 PM IST PTC India Financial - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Oct 24, 2025, 1:02 AM IST PTC India Financial - Announcement under Regulation ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Shares of PTC India Financial Services Ltd. surged over 15% on Friday, October 24, following the company's September quarter results, marking its third consecutive day of gains. Friday's rally is the ...